{"componentChunkName":"component---src-templates-study-details-page-js","path":"/en/study/CAL30001","result":{"data":{"studyNotFoundJson":{"title":"Study not found","content":{"childMarkdownRemark":{"html":"<p>If you entered a web address please check it was correct.</p>\n<p>You can also try <a href=\"/en/studies\">Search Page</a> to find the study you are looking for.</p>"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"<p>A unique number for a study given by ViiV.</p>"}},"ctGov":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.</p>"}},"eudraCT":{"childMarkdownRemark":{"html":"<p>This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.</p>"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"NCT00044577","ctis_id":"","HasResults":"false","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"","IpdInfoTypeIcf":"","IpdInfoTypeCsr":"","IpdInfoTypeProtocol":"","IpdInfoTypeSap":"","IpdTimeFrame":"","IpdUrl":"","IsFlexibleTrial":false,"IsReleasedToCtGov":"true","MaskingInfo":{"masked_assessor":"false","masked_caregiver":"false","masked_investigator":"false","masked_subject":"false","masking_description":"","no_masking":""},"PatientLevelData":"false","SharingIpd":"","acronym":"","allocation":"Randomized","arm_groups":[],"assignment":"Parallel Assignment","brief_summary":"A 48-week study to investigate the safety and effectiveness of a new compact formulation of two already FDA-approved anti-HIV drugs in subjects who have already been receiving treatment for their HIV infection.","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects","conditions":[{"DisplayValue":"Human Immunodeficiency Virus (HIV)","DisplayValue_OneLinkTx":"","InternalValue":"CON_HIV","LookupValue":"Infection, Human Immunodeficiency Virus I","LookupValue_OneLinkTx":""}],"created_date":"09/15/2018 17:36:53","criteria":"Inclusion Criteria: - Antiretroviral therapy (ART) experienced and currently receiving a stable regimen containing 3 nucleoside reverse transcriptase inhibitors (NRTIs), or 2 NRTIs plus a protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitors (NNRTI) for at least 3 months (there should be no significant ART modifications for at least 3 months and no ART change anticipated between Screening and initiation of the study therapy). - Patients must be naive to tenofovir. - HIV-1 RNA level > 1000 copies/ml on at least one occasion within 21 days of study entry. - A CD4 cell count > 50 cells/mm3. - Specified viral genotypes. Exclusion Criteria: - Pregnant or breast-feeding women. - Has an active diagnosis of AIDS. - Additional qualifying criteria to be determined by the physician.","detailed_description":"A phase III, randomized, open-label, parallel, multicenter study to evaluate treatment with fixed-dose combination of abacavir/lamivudine (600mg/300mg) once-daily versus abacavir (300mg) twice-daily and lamivudine (300mg) once-daily in combination with tenofovir once-daily and a new PI or NNRTI for 48 weeks in ART-experienced HIV-1 infected patients.","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"Phase 3","display_phase_internal":"PHASE_3","display_status":"Completed","display_status_internal":"RECSTATUS_I_COMPLETED","endpoint":"","enrollment":"166","exclusion":"","gender":"Both","gender_based":"","gender_description":"","healthy_volunteers":"No","id":"2aca0b1d-9682-5dec-8cf4-5016107a4e75","internal":{"content":null,"contentDigest":"da3a42fd6dce9c8833cf1e0b0e8d1c39","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion Criteria: - Antiretroviral therapy (ART) experienced and currently receiving a stable regimen containing 3 nucleoside reverse transcriptase inhibitors (NRTIs), or 2 NRTIs plus a protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitors (NNRTI) for at least 3 months (there should be no significant ART modifications for at least 3 months and no ART change anticipated between Screening and initiation of the study therapy). - Patients must be naive to tenofovir. - HIV-1 RNA level > 1000 copies/ml on at least one occasion within 21 days of study entry. - A CD4 cell count > 50 cells/mm3. - Specified viral genotypes. Exclusion Criteria: - Pregnant or breast-feeding women. - Has an active diagnosis of AIDS. - Additional qualifying criteria to be determined by the physician.","interventions":[{"arm_group_label":"","intervention_description":"","intervention_name":"abacavir/lamivudine","intervention_type":"Drug"},{"arm_group_label":"","intervention_description":"","intervention_name":"abacavir","intervention_type":"Drug"},{"arm_group_label":"","intervention_description":"","intervention_name":"lamivudine","intervention_type":"Drug"},{"arm_group_label":"","intervention_description":"","intervention_name":"tenofovir","intervention_type":"Drug"}],"interventional_subtype":"Treatment","is_fda_regulated":null,"is_high_value":false,"is_ind_study":true,"keywords":["HIV-1 Abacavir Lamivudine Tenofovir"],"last_follow_up_date":null,"links":[],"locations":[{"City":"Verona","Latitude":"45.3833153","CountryDisplay":"Italy","Longitude":"10.9903978","Name":"GSK Investigational Site","StateDisplay":"Veneto","PostalCode":"37135","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Columbia","Latitude":"34.0258687","CountryDisplay":"United States","Longitude":"-80.9594751","Name":"GSK Investigational Site","StateDisplay":"South Carolina","PostalCode":"29206-4713","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Barcelona","Latitude":"41.3850639","CountryDisplay":"Spain","Longitude":"2.1734035","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"8400","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Oakland","Latitude":"37.8015517","CountryDisplay":"United States","Longitude":"-122.2143323","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"94602","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Barcelona","Latitude":"41.3899238","CountryDisplay":"Spain","Longitude":"2.1511635","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"08036","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Montreal","Latitude":"45.5152072","CountryDisplay":"Canada","Longitude":"-73.5562284","Name":"GSK Investigational Site","StateDisplay":"Québec","PostalCode":"H2L 5B1","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Fort Lauderdale","Latitude":"26.1897731","CountryDisplay":"United States","Longitude":"-80.1037721","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33308","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Atlanta","Latitude":"33.8676889","CountryDisplay":"United States","Longitude":"-84.4645184","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30339","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Dallas","Latitude":"32.7457134","CountryDisplay":"United States","Longitude":"-96.8458204","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"75208","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Madrid","Latitude":"40.3961489","CountryDisplay":"Spain","Longitude":"-3.7485874","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"28047","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Dallas","Latitude":"32.799475","CountryDisplay":"United States","Longitude":"-96.7868794","Name":"GSK Investigational Site","StateDisplay":"Texas","PostalCode":"75204","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Torino","Latitude":"45.0963655","CountryDisplay":"Italy","Longitude":"7.6636292","Name":"GSK Investigational Site","StateDisplay":"Piemonte","PostalCode":"10149","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Muenchen","Latitude":"48.1443383","CountryDisplay":"Germany","Longitude":"11.5548236","Name":"GSK Investigational Site","StateDisplay":"Bayern","PostalCode":"80335","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Fort Lauderdale","Latitude":"26.0977657","CountryDisplay":"United States","Longitude":"-80.1261093","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33316","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Lisboa","Latitude":"38.7222524","CountryDisplay":"Portugal","Longitude":"-9.1393366","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1769-001","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Fort Lauderdale","Latitude":"25.750008","CountryDisplay":"United States","Longitude":"-80.241826","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33145","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"London","Latitude":"51.5170141","CountryDisplay":"United Kingdom","Longitude":"-0.1742622","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"W2 1NY","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Milano","Latitude":"45.5145841","CountryDisplay":"Italy","Longitude":"9.1358629","Name":"GSK Investigational Site","StateDisplay":"Lombardia","PostalCode":"20157","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Faro","Latitude":"37.0239138","CountryDisplay":"Portugal","Longitude":"-7.9280769","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"8000-386","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"London","Latitude":"51.5531762","CountryDisplay":"United Kingdom","Longitude":"-0.1652792","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"NW3 2QG","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Leuven","Latitude":"50.8798438","CountryDisplay":"Belgium","Longitude":"4.7005176","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"3000","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Marbella","Latitude":"36.5154127","CountryDisplay":"Spain","Longitude":"-4.9198949","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"29600","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Fort Myers","Latitude":"26.6235485","CountryDisplay":"United States","Longitude":"-81.8770671","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33901","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Miami Beach","Latitude":"25.8176795","CountryDisplay":"United States","Longitude":"-80.1372757","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33140","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Cascais","Latitude":"38.7144586","CountryDisplay":"Portugal","Longitude":"-9.4505993","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"2750","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Liege","Latitude":"50.6350757","CountryDisplay":"Belgium","Longitude":"5.5628874","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"4000","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Manchester","Latitude":"53.5191895","CountryDisplay":"United Kingdom","Longitude":"-2.2276047","Name":"GSK Investigational Site","StateDisplay":"Lancashire","PostalCode":"M8 5RB","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"London","Latitude":"51.426561","CountryDisplay":"United Kingdom","Longitude":"-0.1760824","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"SW17 0QT","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Braga","Latitude":"41.5494265","CountryDisplay":"Portugal","Longitude":"-8.423575","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"4700-308","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Paris Cedex 13","Latitude":"48.856614","CountryDisplay":"France","Longitude":"2.3522219","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"75651","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Atlanta","Latitude":"33.7717008","CountryDisplay":"United States","Longitude":"-84.3726049","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30308","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Seattle","Latitude":"47.6015566","CountryDisplay":"United States","Longitude":"-122.3323351","Name":"GSK Investigational Site","StateDisplay":"Washington","PostalCode":"98104","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Toronto","Latitude":"43.6538007","CountryDisplay":"Canada","Longitude":"-79.3778814","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M5B 1W8","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Plantation","Latitude":"26.1218038","CountryDisplay":"United States","Longitude":"-80.2209773","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33317","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Le Kremlin Bicêtre Cedex","Latitude":"48.810108","CountryDisplay":"France","Longitude":"2.356972","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"94275","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"London","Latitude":"51.4673518","CountryDisplay":"United Kingdom","Longitude":"-0.0926719","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"SE5 9RS","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Orlando","Latitude":"28.5085825","CountryDisplay":"United States","Longitude":"-81.3564411","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"32806","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Augusta","Latitude":"33.4706725","CountryDisplay":"United States","Longitude":"-81.9861463","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30912","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Garches","Latitude":"48.8466822","CountryDisplay":"France","Longitude":"2.1894188","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"92380","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Bruxelles","Latitude":"50.8427501","CountryDisplay":"Belgium","Longitude":"4.3515499","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"1000","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hamburg","Latitude":"53.5580847","CountryDisplay":"Germany","Longitude":"10.011979","Name":"GSK Investigational Site","StateDisplay":"Hamburg","PostalCode":"20099","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"St. Louis","Latitude":"38.647459","CountryDisplay":"United States","Longitude":"-90.25731","Name":"GSK Investigational Site","StateDisplay":"Missouri","PostalCode":"63108","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Sainte-Foy","Latitude":"46.7691394","CountryDisplay":"Canada","Longitude":"-71.2832751","Name":"GSK Investigational Site","StateDisplay":"Québec","PostalCode":"G1V 4G2","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Indianapolis","Latitude":"39.7794767","CountryDisplay":"United States","Longitude":"-86.1700894","Name":"GSK Investigational Site","StateDisplay":"Indiana","PostalCode":"46202","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"London","Latitude":"51.4847527","CountryDisplay":"United Kingdom","Longitude":"-0.1836283","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"SW10 9TH","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Orlando","Latitude":"28.5747416","CountryDisplay":"United States","Longitude":"-81.3949264","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"32804","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hampton","Latitude":"37.0538822","CountryDisplay":"United States","Longitude":"-76.3984537","Name":"GSK Investigational Site","StateDisplay":"Virginia","PostalCode":"23666","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Frankfurt","Latitude":"50.1109221","CountryDisplay":"Germany","Longitude":"8.6821267","Name":"GSK Investigational Site","StateDisplay":"Hessen","PostalCode":"60590","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"New Orleans","Latitude":"29.9219677","CountryDisplay":"United States","Longitude":"-90.1073935","Name":"GSK Investigational Site","StateDisplay":"Louisiana","PostalCode":"70115","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Lisboa","Latitude":"38.7222524","CountryDisplay":"Portugal","Longitude":"-9.1393366","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":null,"StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Philadelphia","Latitude":"39.9915379","CountryDisplay":"United States","Longitude":"-75.2187346","Name":"GSK Investigational Site","StateDisplay":"Pennsylvania","PostalCode":"19131","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Montreal","Latitude":"45.5179048","CountryDisplay":"Canada","Longitude":"-73.558878","Name":"GSK Investigational Site","StateDisplay":"Québec","PostalCode":"H2L 4P9","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hannover","Latitude":"52.3763832","CountryDisplay":"Germany","Longitude":"9.8026933","Name":"GSK Investigational Site","StateDisplay":"Niedersachsen","PostalCode":"30625","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Vancouver","Latitude":"49.2810099","CountryDisplay":"Canada","Longitude":"-123.1287947","Name":"GSK Investigational Site","StateDisplay":"British Columbia","PostalCode":"V6Z 1Y6","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Madrid","Latitude":"40.4473608","CountryDisplay":"Spain","Longitude":"-3.7384311","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"28040","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Lyon Cedex 03","Latitude":"45.764043","CountryDisplay":"France","Longitude":"4.835659","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"69437","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Toronto","Latitude":"43.6587103","CountryDisplay":"Canada","Longitude":"-79.3875585","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M5G 2C4","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Thornton Heath","Latitude":"51.3894138","CountryDisplay":"United Kingdom","Longitude":"-0.1101497","Name":"GSK Investigational Site","StateDisplay":"Surrey","PostalCode":"CR7 7YE","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Toronto","Latitude":"43.7215696","CountryDisplay":"Canada","Longitude":"-79.3768256","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"M4N 3M5","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Hannover","Latitude":"52.3749839","CountryDisplay":"Germany","Longitude":"9.7388153","Name":"GSK Investigational Site","StateDisplay":"Niedersachsen","PostalCode":"30159","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Ferrara","Latitude":"44.8524824","CountryDisplay":"Italy","Longitude":"11.7193789","Name":"GSK Investigational Site","StateDisplay":"Emilia-Romagna","PostalCode":"44100","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Philadelphia","Latitude":"39.9556241","CountryDisplay":"United States","Longitude":"-75.1647529","Name":"GSK Investigational Site","StateDisplay":"Pennsylvania","PostalCode":"19102","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Modena","Latitude":"44.647128","CountryDisplay":"Italy","Longitude":"10.9252269","Name":"GSK Investigational Site","StateDisplay":"Emilia-Romagna","PostalCode":"41100","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Brescia","Latitude":"45.5203846","CountryDisplay":"Italy","Longitude":"10.1857711","Name":"GSK Investigational Site","StateDisplay":"Lombardia","PostalCode":"25125","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Los Angeles","Latitude":"34.1147313","CountryDisplay":"United States","Longitude":"-118.3637264","Name":"GSK Investigational Site","StateDisplay":"California","PostalCode":"90046","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Jacksonville","Latitude":"30.346791","CountryDisplay":"United States","Longitude":"-81.6418656","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"32206","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Akron","Latitude":"41.0801473","CountryDisplay":"United States","Longitude":"-81.5020328","Name":"GSK Investigational Site","StateDisplay":"Ohio","PostalCode":"44304","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Charlotte","Latitude":"35.1811188","CountryDisplay":"United States","Longitude":"-80.8488498","Name":"GSK Investigational Site","StateDisplay":"North Carolina","PostalCode":"28209","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Stony Brook","Latitude":"40.9132244","CountryDisplay":"United States","Longitude":"-73.1261091","Name":"GSK Investigational Site","StateDisplay":"New York","PostalCode":"11794","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Atlanta","Latitude":"33.776402","CountryDisplay":"United States","Longitude":"-84.38926","Name":"GSK Investigational Site","StateDisplay":"Georgia","PostalCode":"30308/30309","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Ottawa","Latitude":"45.4227425","CountryDisplay":"Canada","Longitude":"-75.6824915","Name":"GSK Investigational Site","StateDisplay":"Ontario","PostalCode":"K1N 6N5","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Tampa","Latitude":"27.9552692","CountryDisplay":"United States","Longitude":"-82.4563199","Name":"GSK Investigational Site","StateDisplay":"Florida","PostalCode":"33602","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Elche (Alicante)","Latitude":"38.2751042","CountryDisplay":"Spain","Longitude":"-0.6749327","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"03202","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Coimbra","Latitude":"40.2191523","CountryDisplay":"Portugal","Longitude":"-8.4098211","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"3000-075","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"},{"City":"Bronx","Latitude":"40.8687887","CountryDisplay":"United States","Longitude":"-73.8977693","Name":"GSK Investigational Site","StateDisplay":"New York","PostalCode":"10468","StatusDisplay":"Completed","StatusDisplayInternal":"LOCSTATUS_COMPLETED","StatusMapped":"Study Complete"},{"City":"Levallois-Perret","Latitude":"48.893217","CountryDisplay":"France","Longitude":"2.287864","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"92300","StatusDisplay":"Terminated","StatusDisplayInternal":"LOCSTATUS_TERMINATED","StatusMapped":"Terminated/Withdrawn"}],"masking":"Open Label","maximum_age_raw":"N/A N/A","maximum_age":"N/A","minimum_age":"18","minimum_age_raw":"18 years","modified_date":"10/01/2018 23:01:14","number_of_arms":"","observational_design":{"biospecimen_description":"","biospecimen_retention":"","number_of_groups":"","observational_study_design":"","patient_registry":"","target_duration_quantity":"","target_duration_units":"","timing":""},"official_title":"See Detailed Description","org_study_id":"CAL30001","overall_contact":{"email":"GSKClinicalSupportHD@gsk.com","last_name":"Call Center","phone":"877-379-3718"},"overall_status":"Completed - Interventional","oversight_info":{"exported_from_us":"","fda_regulated_device":"","fda_regulated_drug":"","ped_postmarket_surv":"","has_dmc":false,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"3","primary_compl_date":null,"primary_outcomes":[{"outcome_description":"","outcome_measure":"HIV viral load response as measured by change from baseline in HIV-1 RNA over 24 and 48 weeks. Safety","outcome_time_frame":"48 weeks","outcome_safety_issue":null}],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":"","outcome_measure":"Viral load response T-cell count Health Outcomes Resistance","outcome_time_frame":"","outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"None","lead_sponsor":"ViiV Healthcare","collaborators":[]},"start_date":"07/01/2002 00:00:00","study_type":"Interventional","therapeutic_area":"Infectious Diseases","citations":[{"citation":"EFFICACY AND SAFETY OF A ONCE DAILY FIXED-DOSE COMBINATION OF ABACAVIR/LAMIVUDINE (ABC/3TC) [FDC ] VERSUS ABC TWICE DAILY AND 3TC ONCE DAILY AS SEPARATE ENTITIES [SE] IN ART-EXPERIENCED HIV-1 INFECTED SUBJECTS (CAL30001): 48 WEEK DATA. Clumeck, N., LaMarca, A., Fu, K., Gordon, D., Craig, C., Zhao, H. , Paes, D., and Scott, T. (WePe6.3C13), 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro; Brazil, 7/24/2005","is_results_ref":"Yes","pubmed_id":""},{"citation":"C Craig, C Stone, T Bonny, K Fu. Similar virology findings in ABC/3TC fixed dose combination (FDC) OAD compared with standard dosing in experienced subjects (CAL30001, ALTO). 7th ICDTHI, Glasgow, UK, 14–18 November 2004. Abstract 98","is_results_ref":"Yes","pubmed_id":""},{"citation":"Clumeck N, Lamarca A, Fu K, Gordon D, Craig C, Zhao H, Paes D, Scott T. Safety and efficacy of a once daily (OAD) Fixed-Dose Combination (FDC) of ABC/3TC [FDC arm] versus ABC twice daily (BID) and 3TC OAD as separate entities [SE arm] in ART-Experienced HIV-1 Infected Patients. 44th ICAAC, Washington, DC, 30 October–2 November 2004. Abstr. H-558","is_results_ref":"Yes","pubmed_id":""}],"is_section_801":null}},"pageContext":{"studyId":"CAL30001"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}